ArticleAbdominal radiology (New York)2026
Effects of partial splenic embolization and portosystemic shunt occlusion on portal venous hemodynamics using 4D flow MRI.
Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
purposeTo quantitatively evaluate changes in portal venous hemodynamics after partial splenic embolization (PSE) and portosystemic shunt occlusion (PSO) using four-dimensional (4D) flow magnetic resonance imaging (MRI).
methodsThis retrospective cohort study included 30 procedures (16 PSE and 14 PSO) performed between 2019 and 2025. Flow rates were measured in the main portal vein (MPV), splenic vein (SpV), superior mesenteric vein (SMV), and portosystemic shunts (PSS) using pre- and post-procedural 4D flow MRI. For PSE, correlations were assessed between changes in MPV and SpV flow, and between vessel-specific flow change ratios and the embolic volume ratio. For PSO, changes in MPV flow were compared based on whether all PSS were treated, and correlation was assessed between flow changes in MPV and PSS flow.
resultsAfter PSE, MPV flow decreased (median, 751.0 to 441.5 mL/min; p = 0.025) as did SpV flow (482.5 to 323.0 mL/min; p = 0.001), whereas SMV flow remained unchanged. Changes in MPV and SpV flow were strongly correlated (ρ = 0.726, p = 0.002). The embolic volume ratio showed a moderate correlation with the SpV flow change ratio (ρ = 0.563, p = 0.036), but not with the MPV flow change ratio. After PSO, MPV flow increased (544.5 to 692.5 mL/min; p < 0.001), along with SpV flow (63.0 to 231.5 mL/min; p = 0.001), while SMV flow did not change significantly. The increase in MPV flow was greater when all PSS were treated than when they were not (140.0 vs. 17.0 mL/min; p = 0.019), and was not correlated with PSS flow.
conclusion4D flow MRI demonstrates that PSE decreases portal and splenic venous flow, whereas PSO increases both. These findings provide quantitative insight into complex treatment-related hemodynamic changes in the portal venous system.
Indexed as
Identifiers
42089988What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.